Quest Diagnostics 2003 Annual Report Download - page 108

Download and view the complete annual report

Please find page 108 of the 2003 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 109

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109

INVESTOR INFORM ATION
COM MON STOCK
Quest Diagnostics Incorporated
(ticker symbol: DGX ) shares
are listed on the New York Stock
Exchange. Options on
Quest Diagnostics shares are
traded on the Chicago Board
Options Exchange.
ANNUAL MEETING
The annual meeting of
stockholders will be held on
Tuesday, May 4, 2004, at the
Short Hills Hilton, Short Hills,
New Jersey at 10:30 A.M. A proxy
statement and annual report were
mailed to stockholders of record
as of March 8, 2004.
CORPORATE GOVERNANCE
Corporate Governance Guidelines,
the Code of Business Ethics and
Committee Charters are available
at the Quest Diagnostics web site
on the Internet:
www.questdiagnostics.com
Inquiries to the Board of
Directors may be sent via e-mail to:
LeadIndependentDirector@
questdiagnostics.com
ADDITIONAL INFORM ATION
Address all inquiries to:
Investor Relations Department
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608
(201) 393-5030
E-mail:
investor@questdiagnostics.com
ANNUAL REPORT ON FORM 10-K
A copy of the Quest Diagnostics
2003 Annual Report on Form 10-K,
filed with the Securities and
Exchange Commission, is contained
within this Annual Report.
Additional copies are available
without charge by contacting the
Investor Relations Department.
INTERNET ACCESS
Corporate news releases, our
Annual Report, Forms 10-K and
10-Q and other information
about the company, including
locations of facilities, are available
at the Quest Diagnostics web site
on the Internet:
www.questdiagnostics.com
TRANSFER AGENT
AND REGISTRAR
National City Bank acts as transfer
agent and registrar and dividend
paying agent, and maintains
all stockholder records for
Quest Diagnostics. If you have
questions about the shares of stock
that you own; wish to report a
change of address or lost stock
certificates or dividend checks;
or would like to enroll in the
companys automatic dividend
reinvestment or direct deposit
program, please contact
National City Bank directly:
National City Bank
Shareholder Services
P. O. Box 92301
Cleveland, Ohio 44193-0900
(800) 622-6757
E-mail:
CORPORATE HEADQUARTERS
One Malcolm Avenue
Teterboro, New Jersey 07608
(201) 393-5000
TRADEMARKS
Quest Diagnostics, Quest, the
Sun-Q logo, eMaxx, ChartMaxx,
Quest on Demand, Nichols Institute
and Unilab are registered
trademarks of Quest Diagnostics.
MedPlus is a registered trademark
of MedPlus, Inc., a wholly-owned
subsidiary of Quest Diagnostics.
Cardio CRP is a trademark of
Quest Diagnostics.
InSure is a trademark of
Enterix Inc.
Neither this report nor any
statement contained herein is
furnished in connection with any
offering of securities or for the
purpose of promoting or
influencing the sale of securities.
© 2004 Quest Diagnostics Incorporated.
All rights reserved.
Design: INC DESIGN, incdesign.com
Printed on recycled paper.
shareholder.inquiries@nationalcity.com